American International Group’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,016
| Closed | -$43K | – | 39 |
|
|
2024
Q1 | $43K | Buy |
6,016
+1,695
| +39% | +$12.1K | ﹤0.01% | 2818 |
|
|
2023
Q4 | $21.3K | Sell |
4,321
-17
| -0.4% | -$84 | ﹤0.01% | 2957 |
|
|
2023
Q3 | $41.5K | Buy |
4,338
+155
| +4% | +$1.48K | ﹤0.01% | 2863 |
|
|
2023
Q2 | $54.2K | Buy |
4,183
+5
| +0.1% | +$65 | ﹤0.01% | 2862 |
|
|
2023
Q1 | $53K | Buy |
+4,178
| New | +$53K | ﹤0.01% | 2692 |
|